Skip to main content
Title Sort ascending Pub Year Author SearchLink
Metal-organic frameworks for analytical chemistry: from sample collection to chromatographic separation 2012 State Key Laboratory of Medicinal Chemical Biology and Research Center for Analytical Sciences, College of Chemistry, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Accounts of Chemical Research
Periodical, Abbrev.
Acc.Chem.Res.
Pub Date Free Form
15-May
Volume
45
Issue
5
Start Page
734
Other Pages
745
Notes
LR: 20131121; JID: 0157313; 0 (Metals); 0 (Organometallic Compounds); 0 (Polycyclic Hydrocarbons, Aromatic); 059QF0KO0R (Water); J64922108F (Benzene); 2012/03/12 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1520-4898; 0001-4842
Accession Number
PMID: 22404189
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1021/ar2002599 [doi]
Output Language
Unknown(0)
PMID
22404189
Abstract
In modern analytical chemistry researchers pursue novel materials to meet analytical challenges such as improvements in sensitivity, selectivity, and detection limit. Metal-organic frameworks (MOFs) are an emerging class of microporous materials, and their unusual properties such as high surface area, good thermal stability, uniform structured nanoscale cavities, and the availability of in-pore functionality and outer-surface modification are attractive for diverse analytical applications. This Account summarizes our research on the analytical applications of MOFs ranging from sampling to chromatographic separation. MOFs have been either directly used or engineered to meet the demands of various analytical applications. Bulk MOFs with microsized crystals are convenient sorbents for direct application to in-field sampling and solid-phase extraction. Quartz tubes packed with MOF-5 have shown excellent stability, adsorption efficiency, and reproducibility for in-field sampling and trapping of atmospheric formaldehyde. The 2D copper(II) isonicotinate packed microcolumn has demonstrated large enhancement factors and good shape- and size-selectivity when applied to on-line solid-phase extraction of polycyclic aromatic hydrocarbons in water samples. We have explored the molecular sieving effect of MOFs for the efficient enrichment of peptides with simultaneous exclusion of proteins from biological fluids. These results show promise for the future of MOFs in peptidomics research. Moreover, nanosized MOFs and engineered thin films of MOFs are promising materials as novel coatings for solid-phase microextraction. We have developed an in situ hydrothermal growth approach to fabricate thin films of MOF-199 on etched stainless steel wire for solid-phase microextraction of volatile benzene homologues with large enhancement factors and wide linearity. Their high thermal stability and easy-to-engineer nanocrystals make MOFs attractive as new stationary phases to fabricate MOF-coated capillaries for high-resolution gas chromatography (GC). We have explored a dynamic coating approach to fabricate a MOF-coated capillary for the GC separation of important raw chemicals and persistent organic pollutants with high resolution and excellent selectivity. We have combined a MOF-coated fiber for solid-phase microextraction with a MOF-coated capillary for GC separation, which provides an effective MOF-based tandem molecular sieve platform for selective microextraction and high-resolution GC separation of target analytes in complex samples. Microsized MOFs with good solvent stability are attractive stationary phases for high-performance liquid chromatography (HPLC). These materials have shown high resolution and good selectivity and reproducibility in both the normal-phase HPLC separation of fullerenes and substituted aromatics on MIL-101 packed columns and position isomers on a MIL-53(Al) packed column and the reversed-phase HPLC separation of a wide range of analytes from nonpolar to polar and acidic to basic solutes. Despite the above achievements, further exploration of MOFs in analytical chemistry is needed. Especially, analytical application-oriented engineering of MOFs is imperative for specific applications.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Gu,Z.Y., Yang,C.X., Chang,N., Yan,X.P.
Original/Translated Title
URL
Date of Electronic
20120312
PMCID
Editors
Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke 2001 Division of Epidemiology, University of Minnesota, Minneapolis 55454, USA. anderson_k@epi.umn.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Journal of the National Cancer Institute
Periodical, Abbrev.
J.Natl.Cancer Inst.
Pub Date Free Form
7-Mar
Volume
93
Issue
5
Start Page
378
Other Pages
381
Notes
LR: 20151119; GR: CA81301/CA/NCI NIH HHS/United States; JID: 7503089; 0 (4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid); 0 (Carcinogens); 0 (Glucuronates); 0 (Nitrosamines); 0 (Tobacco Smoke Pollution); 6M3C89ZY6R (Nicotine)
Place of Publication
United States
ISSN/ISBN
0027-8874; 0027-8874
Accession Number
PMID: 11238699
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; IM
DOI
Output Language
Unknown(0)
PMID
11238699
Abstract
BACKGROUND: Environmental tobacco smoke (ETS) is associated with lung cancer in nonsmokers. Most epidemiologic studies find a higher risk for lung cancer in nonsmoking women married to smokers than in those married to nonsmokers. We measured metabolites of a tobacco-specific lung carcinogen in urine from healthy, nonsmoking women exposed to ETS. METHODS: We recruited women and their partners through advertisements. Couples completed questionnaires on smoking history and demographics, and both partners provided 100 mL of urine; 23 women had male partners who smoked in the home (i.e., exposed women), and 22 women had male partners who did not smoke (i.e., unexposed women). Urine samples were analyzed for nicotine, for cotinine, for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronide (NNAL-Gluc), as well as for creatinine. NNAL and NNAL-Gluc are metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Unpaired Student's t tests were conducted on log-transformed values. All statistical tests are two-sided. RESULTS: Urinary levels of nicotine, cotinine, NNAL, and NNAL-Gluc were statistically significantly higher in exposed women than in unexposed women. Geometric means for these compounds in exposed versus unexposed women, respectively, were as follows: nicotine, 0.050 nmol/mg of creatinine (95% confidence interval [CI] = 0.033 to 0.076) versus 0.008 nmol/mg of creatinine (95% CI = 0.004 to 0.014); cotinine, 0.037 nmol/mg of creatinine (95% CI = 0.022 to 0.061) versus 0.007 nmol/mg of creatinine (95% CI = 0.004 to 0.011); NNAL, 0.013 pmol/mg of creatinine (95% CI = 0.007 to 0.024) versus 0.004 pmol/mg of creatinine (95% CI = 0.002 to 0.007); and NNAL-Gluc, 0.027 pmol/mg of creatinine (95% CI = 0.016 to 0.045) versus 0.004 pmol/mg of creatinine (95% CI = 0.003 to 0.006). CONCLUSIONS: Nonsmoking women exposed to ETS take up and metabolize the tobacco-specific lung carcinogen NNK, which could increase their risk of lung cancer. Within couples, the NNAL plus NNAL-Gluc level in exposed women compared with that of their smoking partners averaged 5.6%. Notably, epidemiologic studies have estimated the excess risk for lung cancer in nonsmoking women exposed to ETS as 1%-2% of that in smokers.
Descriptors
Adult, Aged, Carcinogens/adverse effects/metabolism, Cotinine/urine, Creatinine/urine, Female, Glucuronates/urine, Humans, Lung Neoplasms/etiology/metabolism/urine, Middle Aged, Nicotine/urine, Nitrosamines/urine, Risk, Risk Factors, Smoking/adverse effects, Surveys and Questionnaires, Tobacco Smoke Pollution/adverse effects
Links
Book Title
Database
Publisher
Data Source
Authors
Anderson,K. E., Carmella,S. G., Ye,M., Bliss,R. L., Le,C., Murphy,L., Hecht,S. S.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score 2010 First Cardiology Department, AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Metabolic syndrome and related disorders
Periodical, Abbrev.
Metab.Syndr.Relat.Disord.
Pub Date Free Form
Jun
Volume
8
Issue
3
Start Page
201
Other Pages
208
Notes
JID: 101150318; ppublish
Place of Publication
United States
ISSN/ISBN
1557-8518; 1540-4196
Accession Number
PMID: 20156070
Language
eng
SubFile
Journal Article; IM
DOI
10.1089/met.2009.0059 [doi]
Output Language
Unknown(0)
PMID
20156070
Abstract
BACKGROUND: The association of metabolic syndrome with coronary artery disease (CAD) has been studied extensively. However, little is known about the effect of Framingham risk score (FRS) and metabolic syndrome components on the association of metabolic syndrome with angiographically significant CAD. Our aim was to investigate whether that relationship is influenced by individual's 10-year CAD risk profile as assessed by FRS. Furthermore, we sought to elucidate whether metabolic syndrome is associated with angiographically significant CAD independently of its individual components. METHODS: We studied a consecutive sample of 150 patients undergoing coronary angiography for the evaluation of chest pain. Metabolic syndrome was defined according to the revised National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria, and the 10-year CAD risk was estimated by the FRS. RESULTS: Metabolic syndrome patients had a 2-fold higher CAD prevalence compared to those without metabolic syndrome [odds ratio (OR), 2.004; 95% confidence interval (CI), 1.029-3.905] but this finding was attenuated after adjustment for FRS (OR, 1.770; 95% CI, 0.872-3.594). Stratification of patients into three groups according to FRS revealed that metabolic syndrome predictive ability was confined in those being at <10% 10-year CAD risk. Including metabolic syndrome and its individual components into the same logistic regression model, only the glucose criterion was an independent predictor of angiographically significant CAD (OR, 4.137; 95% CI, 1.477-11.583). CONCLUSIONS: Metabolic syndrome is an independent determinant of angiographically significant CAD only among those individuals at low 10-year risk for future coronary events. Individual components of the syndrome, such as impaired fasting glucose, have a stronger association with CAD than the syndrome as a whole.
Descriptors
Aged, Chi-Square Distribution, Coronary Angiography, Coronary Artery Disease/epidemiology/etiology/radiography, Cross-Sectional Studies, Female, Greece/epidemiology, Humans, Logistic Models, Male, Metabolic Syndrome X/complications/diagnosis/epidemiology, Middle Aged, Odds Ratio, Prevalence, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors
Links
Book Title
Database
Publisher
Data Source
Authors
Konstantinou,D. M., Chatzizisis,Y. S., Louridas,G. E., Giannoglou,G. D.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Meta-analysis of Barrett's esophagus in China 2013 Ying Dong, Xiao-Ying Feng, Chun-Meng Jiang, Department of Gastroenterology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, Liaoning Province, China.; Ying Dong, Xiao-Ying Feng, Chun-Meng Jiang, Department of Gastroenterology,
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
World journal of gastroenterology
Periodical, Abbrev.
World J.Gastroenterol.
Pub Date Free Form
14-Dec
Volume
19
Issue
46
Start Page
8770
Other Pages
8779
Notes
LR: 20151022; JID: 100883448; OID: NLM: PMC3870527; OTO: NOTNLM; 2013/08/14 [received]; 2013/09/23 [revised]; 2013/09/29 [accepted]; ppublish
Place of Publication
China
ISSN/ISBN
2219-2840; 1007-9327
Accession Number
PMID: 24379599
Language
eng
SubFile
Journal Article; Meta-Analysis; Review; IM
DOI
10.3748/wjg.v19.i46.8770 [doi]
Output Language
Unknown(0)
PMID
24379599
Abstract
AIM: To investigate the epidemiology and characteristics of Barrett's esophagus (BE) in China and compare with cases in the west. METHODS: Studies were retrieved from the China National Knowledge Infrastructure and PubMed databases using the terms "Barrett" and "Barrett AND China", respectively, as well as published studies about BE in China from 2000 to 2011. The researchers reviewed the titles and abstracts of all search results to determine whether or not the literature was relevant to the current topic of this research. The references listed in the studies were also searched. Inclusion and exclusion criteria for the literature were appropriately established, and the data reported in the selected studies were analyzed. Finally, a meta-analysis was performed. RESULTS: The current research included 3873 cases of BE from 69 studies. The endoscopic detection rate of BE in China was 1%. The ratio of male to female cases was 1.781 to 1, and the average age of BE patients was 49.07 +/- 5.09 years. Island-type and short-segment BE were the most common endoscopic manifestations, accounting for 4.48% and 80.3%, respectively, of all cases studied. Cardiac-type BE was observed in 40.0% of the cases, representing the most common histological characteristic of the condition. Cancer incidence was 1.418 per 1000 person-years. CONCLUSION: Average age of BE patients in China is lower than in Western countries. Endoscopic detection and cancer incidence were also lower in China.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Dong,Y., Qi,B., Feng,X.Y., Jiang,C.M.
Original/Translated Title
URL
Date of Electronic
PMCID
PMC3870527
Editors
Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett&#39;s esophagus 2010 Michigan Institute for Clinical and Health Research, Ann Arbor, Michigan, USA.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The American Journal of Gastroenterology
Periodical, Abbrev.
Am.J.Gastroenterol.
Pub Date Free Form
Aug
Volume
105
Issue
8
Start Page
1729, 1730
Other Pages
7; quiz 1738
Notes
LR: 20141203; GR: K23 DK079291/DK/NIDDK NIH HHS/United States; GR: K23 DK079291/DK/NIDDK NIH HHS/United States; GR: K23 DK079291-04/DK/NIDDK NIH HHS/United States; JID: 0421030; RF: 52; NIHMS217992; OID: NLM: NIHMS217992; OID: NLM: PMC2916949; 2010/05/18
Place of Publication
United States
ISSN/ISBN
1572-0241; 0002-9270
Accession Number
PMID: 20485283
Language
eng
SubFile
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review; IM
DOI
10.1038/ajg.2010.194 [doi]
Output Language
Unknown(0)
PMID
20485283
Abstract
OBJECTIVES: Esophageal adenocarcinoma (EAC) is a devastating disease that has risen in incidence over the past several decades. Barrett's esophagus (BE) is an associated premalignant lesion. Current preventative efforts rely on endoscopic screening of individuals with gastroesophageal reflux disease (GERD) symptoms and surveillance endoscopy for those with BE. However, some recent studies have found a high prevalence of BE in patients without GERD, and others have found little or no association with GERD. We hypothesized that studies of higher-quality design show weaker associations of GERD with BE, and that GERD is only weakly associated with short-segment Barrett's esophagus (SSBE). METHODS: We performed a systematic literature search in multiple online electronic databases regardless of language. Eligible studies required visualization of columnar mucosa and histological confirmation of intestinal metaplasia, and GERD symptoms ascertained by questionnaire or interview. The highest-quality sampling design was defined a priori by both cases and controls identified among unselected research volunteers ("research design") rather than by patients selected for endoscopy for clinical indications ("clinical design"), which introduces selection and ascertainment bias. A priori, heterogeneity was defined by Cochrane's Q P<0.20 and the inconsistency index (I(2); 25% low, 50% moderate, and 75% high). Heterogeneity of results can reflect significant differences in study design or effect modification by strata of outcomes. RESULTS: Systematic review identified 13,392 citations. Evaluation identified 108 potentially relevant journal articles, of which 26 met eligibility. Of these, 14 studies identified cases of BE and controls based on clinical indication ("clinical design"), and 6 used the "research design." The remaining six studies identified cases of BE from patients undergoing endoscopy for clinical indication and controls among patients without known BE ("cases clinical/controls research"). The summary odds ratio (OR) for the association of GERD with BE from all studies was 2.90 (95% confidence interval (CI), 1.86-4.54), but the results were very heterogeneous (P=0.0001; I(2)=89%). When stratified by BE length and sampling design, the studies with clinical design showed substantial, but heterogeneous, associations with SSBE (OR, 2.38; 95% CI, 1.21-4.70; P=0.02; I(2)=62%), and stronger and homogeneous association with long-segment BE (LSBE; fixed effects OR, 2.96; 95% CI, 1.69-5.19; P=0.25; I(2)=25%). In the research study design, stratifying by length of BE resolved the heterogeneity and showed a strong association between GERD and LSBE (fixed effects OR, 4.92; 95% CI, 2.01-12.0; P=0.30; I(2)=19%) and no association with SSBE (fixed effects OR, 1.15; 95% CI, 0.763-1.73; P=0.84; I(2)=0%). Funnel plots showed potential evidence for bias against dissemination of small negative studies. CONCLUSIONS: In the highest-quality studies, GERD symptoms are not associated with SSBE, but increased the odds of LSBE by fivefold. GERD symptoms can serve as a reliable predictor of LSBE, but not SSBE. If SSBE is considered worthy of identification, then current screening practices do not select patients at risk for endoscopy, and alternative methods of selection for screening need to be developed.
Descriptors
Barrett Esophagus/etiology/pathology/prevention & control, Esophagoscopy, Gastroesophageal Reflux/complications/pathology, Humans, Precancerous Conditions/etiology/pathology/prevention & control, Risk
Links
Book Title
Database
Publisher
Data Source
Authors
Taylor,J. B., Rubenstein,J. H.
Original/Translated Title
URL
Date of Electronic
20100518
PMCID
PMC2916949
Editors
Merkel Cell Carcinoma: rising incidence in the East of England 2016 Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.; National Cancer Registration Service, Public Health England, Cambridge, UK.; Department of Pathology, Norfolk and Norwich University Hospital, Norwich, UK.; Department of De
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Journal of the European Academy of Dermatology and Venereology : JEADV
Periodical, Abbrev.
J.Eur.Acad.Dermatol.Venereol.
Pub Date Free Form
12-Aug
Volume
Issue
Start Page
Other Pages
Notes
LR: 20160812; CI: (c) 2016; JID: 9216037; 2016/03/31 [received]; 2016/05/19 [accepted]; aheadofprint
Place of Publication
ISSN/ISBN
1468-3083; 0926-9959
Accession Number
PMID: 27515234
Language
ENG
SubFile
JOURNAL ARTICLE
DOI
10.1111/jdv.13828 [doi]
Output Language
Unknown(0)
PMID
27515234
Abstract
BACKGROUND: Merkel Cell Carcinoma (MCC) is an infrequent but highly aggressive skin cancer. Five-year survival rates are poor, as there are high rates of metastases at primary diagnoses. Recurrences are also common. There is controversy about actual incidence rates which vary considerably between developed countries with majority populations of fair skin types. OBJECTIVES: We report the age-standardized incidence rates of MCC for both males and females from the East of England, and use linear regression analyses to estimate numbers of cases for 2020 and 2025 to aid healthcare planning and allocation of resources. METHODS: All cases of MCC diagnosed histopathologically between 1st January 2004 and 31st December 2013 were extracted from the databases of the Eastern Office, National Cancer Registration Service, Public Health England, and the Pathology department of the Norfolk and Norwich University Hospital, which serves as the tertiary referral centre for the region. Age-standardization incidence rate calculations (ASIs) and linear regression analyses were performed. RESULTS: The ASIs for males and females were 0.70 and 1.08 per 100 000 person-years respectively. The total age-adjusted incidence rate was therefore 1.78 per 100 000 person-years. The ratio of female: male disease was 3:2. The total number of cases for this region over the time period studied was 73. There has been a threefold increase over this period. Estimated cases for this region are 17 in 2020, and 22 in 2025. Estimated UK cases for 2020 are 920, and 1134 in 2025. CONCLUSIONS: MCC is increasing steadily in the East of England, and has risen threefold over the last 10 years and is similar to the highest reported rates from Western Australia. These data are 12-fold higher than previous UK estimates, and suggest that the incidence rate is also rising in other regions of the UK.
Descriptors
Links
Book Title
Database
Publisher
European Academy of Dermatology and Venereology
Data Source
Authors
Goon,P.K., Greenberg,D.C., Igali,L., Levell,N.J.
Original/Translated Title
URL
Date of Electronic
20160812
PMCID
Editors
Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES) 2013 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. mijones@jhsph.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Periodical, Abbrev.
Cancer Epidemiol.Biomarkers Prev.
Pub Date Free Form
Feb
Volume
22
Issue
2
Start Page
224
Other Pages
232
Notes
LR: 20151119; GR: R03 CA153959/CA/NCI NIH HHS/United States; GR: R03CA153959/CA/NCI NIH HHS/United States; GR: T32 HL007024/HL/NHLBI NIH HHS/United States; GR: T32HL007024/HL/NHLBI NIH HHS/United States; JID: 9200608; 0 (4-(methylnitrosamino)-1-(3-pyridyl
Place of Publication
United States
ISSN/ISBN
1538-7755; 1055-9965
Accession Number
PMID: 23250935
Language
eng
SubFile
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; IM
DOI
10.1158/1055-9965.EPI-12-0912 [doi]
Output Language
Unknown(0)
PMID
23250935
Abstract
BACKGROUND: In the United States, cigarette flavorings are banned, with the exception of menthol. The cooling effects of menthol could facilitate the absorption of tobacco toxicants. We examined levels of biomarkers of tobacco exposure among U.S. smokers of menthol and nonmenthol cigarettes. METHODS: We studied 4,603 White, African-American, and Mexican-American current smokers 20 years of age or older who participated in the National Health and Nutrition Examination Survey (NHANES) from 1999 through 2010 and had data on cigarette type and serum cotinine, blood cadmium, and blood lead concentrations. Urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL) was studied in 1,607 participants with available measures. RESULTS: A total of 3,210 (74.3%) participants smoked nonmenthol cigarettes compared with 1,393 (25.7%) participants who smoked menthol cigarettes. The geometric mean concentrations comparing smokers of nonmenthol with menthol cigarettes were 163.1 versus 175.9 ng/mL for serum cotinine; 0.95 versus 1.02 mug/L for blood cadmium; 1.87 versus 1.75 mug/dL for blood lead; and 0.27 versus 0.23 ng/mL for urine NNAL. After multivariable adjustment, the ratios [95% confidence interval (CI)] comparing smokers of menthol with nonmenthol cigarettes were 1.03 (0.95-1.11) for cotinine, 1.10 (1.04-1.16) for cadmium, 0.95 (0.90-1.01) for lead, and 0.81 (0.65-1.01) for NNAL. CONCLUSIONS: In a representative sample of U.S. adult smokers, current menthol cigarette use was associated with increased concentration of blood cadmium, an established carcinogen and highly toxic metal, but not with other biomarkers. IMPACT: These findings provide information regarding possible differences in exposure to toxic constituents among menthol cigarette smokers compared with nonmenthol cigarette smokers.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Jones,M.R., Apelberg,B.J., Tellez-Plaza,M., Samet,J.M., Navas-Acien,A.
Original/Translated Title
URL
Date of Electronic
20121218
PMCID
PMC3565051
Editors
Menthol cigarettes and indicators of tobacco dependence among adolescents 2007 University of Medicine and Dentistry of New Jersey, School of Public Health, 317 George Street, Suite 209, New Brunswick, New Jersey 08901, USA. olivia.wackowski@umdnj.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Addictive Behaviors
Periodical, Abbrev.
Addict.Behav.
Pub Date Free Form
Sep
Volume
32
Issue
9
Start Page
1964
Other Pages
1969
Notes
LR: 20151119; JID: 7603486; 1490-04-6 (Menthol); 2006/07/19 [received]; 2006/11/17 [revised]; 2006/12/14 [accepted]; 2006/12/22 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
0306-4603; 0306-4603
Accession Number
PMID: 17229528
Language
eng
SubFile
Journal Article; IM
DOI
S0306-4603(06)00403-5 [pii]
Output Language
Unknown(0)
PMID
17229528
Abstract
OBJECTIVES: This study examines measures of nicotine dependence among adolescent menthol and non-menthol cigarette smokers in a nationally representative sample. METHODS: We examined rates of menthol smoking and measures of nicotine dependence among 1345 current established smokers in grades 9-12 who participated in the 2004 National Youth Tobacco Survey. Logistic regression was used to generate an adjusted odds ratio (OR) for menthol smoking for four measures of nicotine dependence, controlling for demographic characteristics and smoking patterns. RESULTS: Approximately 46% of all current established cigarette smokers were menthol smokers. Menthol smokers had 2.6 and 1.6 greater odds than non-menthol smokers for reporting that they could go for less than 1 h before feeling like they need a cigarette and that they experience cravings after not smoking for a while, respectively. CONCLUSIONS: Menthol cigarette smoking was associated with two dependence measures and may be more addictive than regular cigarettes in young smokers. Future research should continue to explore relationships between dependency and menthol use as well as the high prevalence of menthol use among adolescents.
Descriptors
Adolescent, Age Factors, Female, Humans, Male, Menthol, Prevalence, Severity of Illness Index, Surveys and Questionnaires, Tobacco Use Disorder/epidemiology
Links
Book Title
Database
Publisher
Data Source
Authors
Wackowski,O., Delnevo,C. D.
Original/Translated Title
URL
Date of Electronic
20061222
PMCID
Editors
Menthol cigarette smoking among lesbian, gay, bisexual, and transgender adults 2015 Center for Tobacco Control Research and Education, University of California, San Francisco, California. Electronic address: atfall2@uky.edu.; Institute for Pharmaceutical Outcomes and Policy, University of Kentucky, Lexington, Kentucky.; Office on Smoking
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
American Journal of Preventive Medicine
Periodical, Abbrev.
Am.J.Prev.Med.
Pub Date Free Form
Jan
Volume
48
Issue
1
Start Page
93
Other Pages
97
Notes
LR: 20160101; CI: Copyright (c) 2015; GR: CC999999/Intramural CDC HHS/United States; JID: 8704773; 1490-04-6 (Menthol); 6M3C89ZY6R (Nicotine); HHSPA695400; OID: NLM: HHSPA695400; OID: NLM: PMC4454462; 2014/03/03 [received]; 2014/06/20 [revised]; 2014/07/2
Place of Publication
Netherlands
ISSN/ISBN
1873-2607; 0749-3797
Accession Number
PMID: 25245795
Language
eng
SubFile
Journal Article; IM
DOI
10.1016/j.amepre.2014.07.044 [doi]
Output Language
Unknown(0)
PMID
25245795
Abstract
BACKGROUND: Menthol can mask the harshness and taste of tobacco, making menthol cigarettes easier to use and increasing their appeal among vulnerable populations. The tobacco industry has targeted youth, women, and racial minorities with menthol cigarettes, and these groups smoke menthol cigarettes at higher rates. The tobacco industry has also targeted the lesbian, gay, bisexual, and transgender (LGBT) communities with tobacco product marketing. PURPOSE: To assess current menthol cigarette smoking by sexual orientation among a nationally representative sample of U.S. adults. METHODS: Data were obtained from the 2009-2010 National Adult Tobacco Survey, a national landline and cellular telephone survey of non-institutionalized U.S. adults aged >/=18 years, to compare current menthol cigarette smoking between LGBT (n=2,431) and heterosexual/straight (n=110,841) adults. Data were analyzed during January-April 2014 using descriptive statistics and logistic regression adjusted for sex, age, race, and educational attainment. RESULTS: Among all current cigarette smokers, 29.6% reported usually smoking menthol cigarettes in the past 30 days. Menthol use was significantly higher among LGBT smokers, with 36.3% reporting that the cigarettes they usually smoked were menthol compared to 29.3% of heterosexual/straight smokers (p
Descriptors
Links
Book Title
Database
Publisher
American Journal of Preventive Medicine
Data Source
Authors
Fallin,A., Goodin,A.J., King,B.A.
Original/Translated Title
URL
Date of Electronic
20140919
PMCID
PMC4454462
Editors
Menthol cigarette and marijuana use among adolescents 2013 Department of Psychiatry, Yale University School of Medicine, New Haven, CT;
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Dec
Volume
15
Issue
12
Start Page
2094
Other Pages
2099
Notes
LR: 20151119; GR: P50 DA009241/DA/NIDA NIH HHS/United States; GR: P50 DA09421/DA/NIDA NIH HHS/United States; GR: R01DA026450/DA/NIDA NIH HHS/United States; JID: 9815751; 1490-04-6 (Menthol); OID: NLM: PMC3888180; 2013/07/24 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 23884319
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; IM
DOI
10.1093/ntr/ntt102 [doi]
Output Language
Unknown(0)
PMID
23884319
Abstract
INTRODUCTION: Menthol cigarette and marijuana use among adolescents is high; however, little is known about dual use in this age. Thus, we examined these rates among 2 samples of adolescents in Connecticut. METHODS: Study 1 examined a school-wide survey assessing variables related to cigarettes and marijuana among high school students (N = 837 [13% smokers]), and Study 2 examined these factors using baseline data of high school-aged, treatment-seeking, daily cigarette smokers prior to quitting (N = 132). RESULTS: In Study 1, lifetime marijuana use among all adolescents was 33% and past 30-day marijuana use was 21%. Among cigarette smokers, 55% reported smoking menthol cigarettes, 84% reported lifetime marijuana use, and 66% reported past 30-day marijuana use. Multivariate-adjusted logistic regression models indicated that cigarette smokers, when compared with nonsmokers, had greater rates of lifetime (odds ratio [OR] = 10.91) and past 30-day marijuana use (OR = 10.44). Among smokers, use of menthol cigarettes, when compared with use of nonmenthol cigarettes, was associated with greater lifetime (OR = 5.05) but not past 30-day marijuana use. In Study 2 with daily smokers, 59% of adolescents reported use of menthol cigarettes and 66% reported past 30-day marijuana use. Compared with nonmenthol cigarette smokers, menthol cigarette smokers were more likely to report past 30-day marijuana use (OR = 2.44). CONCLUSIONS: Cigarette smoking is associated with marijuana use, and among smokers, menthol cigarette smoking further increased the odds of marijuana use. More research on the dual use of marijuana and tobacco is needed to inform prevention and treatment of substance use.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Kong,G., Singh,N., Camenga,D., Cavallo,D., Krishnan-Sarin,S.
Original/Translated Title
URL
Date of Electronic
20130724
PMCID
PMC3888180
Editors